Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
9.43
-2.21 (-18.99%)
At close: Aug 25, 2025, 4:00 PM
9.25
-0.18 (-1.91%)
After-hours: Aug 25, 2025, 7:53 PM EDT
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
$323,375
Profits / Employee
-$110,425
Market Cap
780.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 713 | 37 | 5.47% |
Dec 31, 2023 | 676 | -43 | -5.98% |
Dec 31, 2022 | 719 | -43 | -5.64% |
Dec 31, 2021 | 762 | 262 | 52.40% |
Dec 31, 2020 | 500 | -21 | -4.03% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VALN News
- 10 hours ago - Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday - Benzinga
- 11 hours ago - Johnson Fistel Investigates Valneva Following FDA Suspension - GlobeNewsWire
- 12 hours ago - Safety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In US - Benzinga
- 21 hours ago - FDA suspends Valneva's chikungunya vaccine license in the U.S. - Reuters
- 21 hours ago - Valneva Announces FDA's Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S. - GlobeNewsWire
- 7 days ago - Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older - GlobeNewsWire
- 13 days ago - Valneva SE (VALN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire